Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript March 24, 2026 Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $0.
Welcome to Fennec Pharmaceuticals' Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. [Operator Instructions]. As a reminder, today's conference call is being recorded.
While each method has its pros and cons, a joint study found that LC-MS provides a clearer, more comprehensive picture of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results